JONATHAN GARCELL: Open Payments
NPI 1801421292 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 4 payments from 4 companies in 2025. Trend: 2023 $371 · 2024 $509 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $109 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: IMDELLTRA (AMG757), RECORLEV, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
